IRTC

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About iRhythm Technologies Inc

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
CEO
Kevin King
Employees
1157
Headquarters

650 Townsend St Ste 500
San Francisco, California 94103-6227
Phone: 14156325700
www.irhythmtech.com

News

ROSEN, A RESPECTED AND LEADING FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IRTC
Feb 24, 2024 16:00pm


Source:Kwhen Finance
Earnings call: iRhythm Technologies reports 20% revenue growth
Feb 23, 2024 09:02am

https://www.investing.com/news/stock-market-news/earnings-call-irhythm-technologies-reports-20-revenue-growth-93CH-3312520


Source:Investing.com
iRhythm Technologies, Inc. (IRTC) Q4 2023 Earnings Call Transcript
Feb 23, 2024 01:58am

No summary available.


Source:Seeking Alpha
iRhythm Technologies, Inc. 2023 Q4 - Results - Earnings Call Presentation
Feb 23, 2024 01:58am

No summary available.


Source:Seeking Alpha
iRhythm Technologies Non-GAAP EPS of -$0.84 misses by $0.23, revenue of $132.5M beats by $2.26M
Feb 22, 2024 21:40pm

No summary available.


Source:Seeking Alpha
Recap: iRhythm Technologies Q4 Earnings
Feb 22, 2024 21:25pm

iRhythm Technologies (NASDAQ: IRTC ) reported its Q4 earnings results on Thursday, February 22, 2024 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings iRhythm Technologies missed estimated earnings by 40.0%, reporting an EPS of $-0.84 versus an … Full story available on Benzinga.com


Source:Benzinga
IRTC SHAREHOLDERS: Shareholders with Significant Losses Should Contact Robbins LLP For Information About Their Rights and Remedies
Feb 20, 2024 18:59pm

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired iRhythm Technologies, Inc. (NASDAQ: IRTC) common stock between January 11, 2022 and May 30, 2023. iRhythm is a digital healthcare company that develops and manufactures heart monitoring devices designed to diagnose arrhythmias. For more information, Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
IRHYTHM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTC
Feb 17, 2024 03:45am


Source:Kwhen Finance
Class Action Filed Against iRhythm Technologies, Inc. (IRTC) - April 8, 2024 Deadline to Join - Contact Levi & Korsinsky
Feb 16, 2024 10:00am

NEW YORK, Feb. 16, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in iRhythm Technologies, Inc. ("iRhythm Technologies" or the "Company") (NASDAQ: IRTC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iRhythm…


Source:PR Newswire